Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Head and Neck Neoplasms 2Lymphedema 1Fibrosis 1Deglutition Disorders 1

Interventions

Magnetic Resonance Spectroscopy 3Blood Specimen Collection 3Specimen Handling 2Simvastatin 2Liver Transplantation 2tremelimumab 1sofosbuvir-velpatasvir drug combination 1epigallocatechin gallate 1durvalumab 1atezolizumab 1apixaban 1User-Centered Design 1Tocopherols 1Surveys and Questionnaires 1Standard of Care 1Sodium Chloride 1Sampling Studies 1Radiotherapy 1Radiation 1Pravastatin 1Phlebotomy 1Pharmaceutical Preparations 1Pentoxifylline 1Patient Navigation 1Neuropsychological Tests 1Musculoskeletal Manipulations 1Memantine 1Losartan 1Ketoprofen 1Gemcitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fibrosis × Pravastatin × 1 year × Clear all
NCT06912763 2026-01-26

Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)

M.D. Anderson Cancer Center

Phase 2 Recruiting
250 enrolled
Head & Neck

Fibrosis, Head and Neck Neoplasms, Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon âš¡